BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8461632)

  • 1. New clues to the pathophysiology of hepatorenal failure.
    Lang F; Gerok W; Häussinger D
    Clin Investig; 1993 Feb; 71(2):93-7. PubMed ID: 8461632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatorenal syndrome.
    Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P; Laffi G; La Villa G; Raggi VC
    Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of Hepatorenal Syndrome.
    Velez JCQ; Latt N; Rodby RA
    Adv Kidney Dis Health; 2024 Mar; 31(2):87-99. PubMed ID: 38649221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of the hepatorenal syndrome and potential for therapy.
    Levy M
    Am J Cardiol; 1987 Dec; 60(17):66I-72I. PubMed ID: 3687808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatorenal syndrome. Studies of the effect of vascular volume and intraperitoneal pressure on renal and hepatic function.
    Cade R; Wagemaker H; Vogel S; Mars D; Hood-Lewis D; Privette M; Peterson J; Schlein E; Hawkins R; Raulerson D
    Am J Med; 1987 Mar; 82(3):427-38. PubMed ID: 3548346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
    Møller S; Henriksen JH
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreases in portal flow trigger a hepatorenal reflex to inhibit renal sodium and water excretion in rats: role of adenosine.
    Ming Z; Smyth DD; Lautt WW
    Hepatology; 2002 Jan; 35(1):167-75. PubMed ID: 11786973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
    Arroyo V; Jiménez W
    J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
    Angeli P; Volpin R; Gerunda G; Craighero R; Roner P; Merenda R; Amodio P; Sticca A; Caregaro L; Maffei-Faccioli A; Gatta A
    Hepatology; 1999 Jun; 29(6):1690-7. PubMed ID: 10347109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on ascites and hepatorenal syndrome.
    Gentilini P; Vizzutti F; Gentilini A; Zipoli M; Foschi M; Romanelli RG
    Dig Liver Dis; 2002 Aug; 34(8):592-605. PubMed ID: 12502217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatorenal syndrome. New perspectives in pathogenesis and treatment.
    Badalamenti S; Graziani G; Salerno F; Ponticelli C
    Arch Intern Med; 1993 Sep; 153(17):1957-67. PubMed ID: 8357280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis.
    Solà E; Ginès P
    Dig Dis; 2015; 33(4):534-8. PubMed ID: 26159270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatorenal syndrome.
    Kramer L; Hörl WH
    Semin Nephrol; 2002 Jul; 22(4):290-301. PubMed ID: 12118394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy.
    Epstein M
    J Am Soc Nephrol; 1994 Apr; 4(10):1735-53. PubMed ID: 8068872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.
    Barbano B; Sardo L; Gigante A; Gasperini ML; Liberatori M; Giraldi GD; Lacanna A; Amoroso A; Cianci R
    Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hepatorenal syndrome.
    Moore K
    Clin Sci (Lond); 1997 May; 92(5):433-43. PubMed ID: 9176015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandins in congestive heart failure and the effects of nonsteroidal anti-inflammatory drugs.
    Cannon PJ
    Am J Med; 1986 Aug; 81(2B):123-32. PubMed ID: 3092662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The liver and the kidney: mutual clearance or mixed intoxication.
    Arroyo V
    Contrib Nephrol; 2007; 156():17-23. PubMed ID: 17464111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.